Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Benitec Ltd (BNIKF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0980 +21.22%
on 09/21/17
0.1600 -25.75%
on 10/17/17
+0.0268 (+29.13%)
since 09/19/17
3-Month
0.0889 +33.63%
on 08/25/17
0.1600 -25.75%
on 10/17/17
+0.0208 (+21.22%)
since 07/19/17
52-Week
0.0641 +85.34%
on 12/16/16
0.2600 -54.31%
on 04/04/17
+0.0538 (+82.77%)
since 10/19/16

Most Recent Stories

More News
U.S. patent granted for Benitec hepatitis B program

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that a new patent relating to the Company's hepatitis B program has been issued in the United States. Titled "HBV...

BNIKF : 0.1188 (-11.34%)
Benitec Biopharma advances OPMD orphan disease program

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce it has developed a new single vector (gene therapy construct) system which uses DNA directed RNA interference (ddRNAi)...

BNIKF : 0.1188 (-11.34%)
How These Biotech Stocks are Faring? -- Cymabay Therapeutics, Benitec Biopharma, Sage Therapeutics, and Catalyst Biosciences

On Tuesday, April 25, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Eight out of nine sectors ended Tuesday's trading session in bullish...

BNTC : 2.67 (+2.30%)
CBAY : 8.18 (-5.43%)
SAGE : 62.92 (+0.13%)
CBIO : 4.98 (-0.70%)
BNIKF : 0.1188 (-11.34%)
Today's Research Reports on Biotech Stocks to Watch: Benitec Biopharma and Paratek Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / April 5, 2017 / On Tuesday, Benitec Biopharma and Paratek Pharmaceuticals both reported FDA trial results and investors moved quickly to take advantage of the good news. Volume...

BNTC : 2.67 (+2.30%)
PRTK : 23.25 (-0.43%)
BNIKF : 0.1188 (-11.34%)
Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that the initial pre-clinical efficacy results of the OPMD program have been published in Nature Communications,...

BNIKF : 0.1188 (-11.34%)
Biotech Stocks Under Scanner -- BioDelivery Sciences, Sage Therapeutics, Benitec Biopharma, and OncoGenex Pharma

On Thursday, March 23, 2017, the NASDAQ Composite ended the trading session at 5,817.69, down 0.07%; the Dow Jones Industrial Average edged 0.02% lower, to finish at 20,656.58; and the S&P 500 closed at...

BNTC : 2.67 (+2.30%)
BDSI : 2.80 (-1.75%)
SAGE : 62.92 (+0.13%)
OGXI : 0.40 (-3.85%)
BNIKF : 0.1188 (-11.34%)
Benitec Biopharma completes second tranche placement to Nant Capital to raise A$5.45 million

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) (Benitec) today announced that in accordance with the Share Subscription Agreement dated 24 October 2016 entered into between Benitec and...

BNIKF : 0.1188 (-11.34%)
Blog Coverage Benitec Biopharma Secures Orphan Drug Designation for its Product Treating Patients with Oculopharyngeal Muscular Dystrophy

Upcoming AWS Coverage on Biogen

BNTC : 2.67 (+2.30%)
BNIKF : 0.1188 (-11.34%)
BIIB : 342.42 (-0.63%)
Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that the European Commission, based on a favourable recommendation from the European Medicines Agency (EMA) Committee...

BNIKF : 0.1188 (-11.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Support & Resistance

2nd Resistance Point 0.1607
1st Resistance Point 0.1473
Last Price 0.1188
1st Support Level 0.1253
2nd Support Level 0.1167

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart